Michael J. Borowitz
Impact in
- Hematology top 0.01%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Hematopoietic Stem Cell Transplantation
- Genetics top 0.05%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Chronic Lymphocytic Leukemia Research
Papers in
-
- Acute Lymphoblastic Leukemia research 166
- Hematology 122
- Acute Myeloid Leukemia Research 71
- Chronic Myeloid Leukemia Treatments 47
- Hematopoietic Stem Cell Transplantation 28
- Co-authors
- Daniel A. Arber (4 shared papers)James W. Vardiman (4 shared papers)Michelle M. Le Beau (3 shared papers)Clara D. Bloomfield (3 shared papers)Robert P. Hasserjian (2 shared papers)Attilio Orazi (1 shared paper)Mario Cazzola (1 shared paper)Jürgen Thiele (2 shared papers)
- Journals
- Blood (84 papers)Journal of Clinical Oncology (40 papers)American Journal of Clinical Pathology (29 papers)Leukemia (11 papers)Biology of Blood and Marrow Transplantation (10 papers)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Michael J. Borowitz
326 papers receiving 22.9k citations
Michael J. Borowitz's Hit Papers
Peers
Comparison fields: 5 of 168
- Hematology 11.3k
- Genetics 5.3k
- Public Health, Environmental and Occupational Health 7.3k
- Pathology and Forensic Medicine 2.9k
- Oncology 4.0k
Countries citing papers authored by Michael J. Borowitz
This map shows the geographic impact of Michael J. Borowitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael J. Borowitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael J. Borowitz more than expected).
Fields of papers citing papers by Michael J. Borowitz
This network shows the impact of papers produced by Michael J. Borowitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael J. Borowitz. The network helps show where Michael J. Borowitz may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael J. Borowitz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 332 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia Hit paper breakdown → | 2016 | 6165 |
| 2 | The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes Hit paper breakdown → | 2009 | 3014 |
| 3 | Effect of Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor on Hematopoietic Reconstitution after High-Dose Chemotherapy and Autologous Bone Marrow Transplantation Hit paper breakdown → | 1988 | 599 |
| 4 | Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children's Oncology Group study Hit paper breakdown → | 2008 | 545 |
| 5 | Improved Early Event-Free Survival With Imatinib in Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia: A Children's Oncology Group Study Hit paper breakdown → | 2009 | 442 |
| 6 | Long-term follow-up of imatinib in pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia: Children's Oncology Group Study AALL0031 Hit paper breakdown → | 2014 | 309 |
| 7 | 2006 | 305 | |
| 8 | 2010 | 248 | |
| 9 | 1993 | 242 | |
| 10 | 2016 | 235 | |
| 11 | 2015 | 228 | |
| 12 | Effect of Postreinduction Therapy Consolidation With Blinatumomab vs Chemotherapy on Disease-Free Survival in Children, Adolescents, and Young Adults With First Relapse of B-Cell Acute Lymphoblastic Leukemia Hit paper breakdown → | 2021 | 220 |
| 13 | 1993 | 215 | |
| 14 | 1981 | 214 | |
| 15 | Antigens of human pancreatic adenocarcinoma cells defined by murine monoclonal antibodies. | 1982 | 201 |
| 16 | 2000 | 192 | |
| 17 | 2012 | 176 | |
| 18 | 2012 | 173 | |
| 19 | 1990 | 170 | |
| 20 | 2015 | 167 |
About Michael J. Borowitz
Michael J. Borowitz is a scholar working on Public Health, Environmental and Occupational Health, Hematology, Pathology and Forensic Medicine, Pediatrics, Perinatology and Child Health and Oncology, having authored 332 papers that have together received 23.5k indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (166 papers), Acute Myeloid Leukemia Research (71 papers), Lymphoma Diagnosis and Treatment (63 papers), Chronic Myeloid Leukemia Treatments (47 papers), Childhood Cancer Survivors' Quality of Life (45 papers), Chronic Lymphocytic Leukemia Research (38 papers), Hematopoietic Stem Cell Transplantation (28 papers) and Monoclonal and Polyclonal Antibodies Research (22 papers). The work is most often cited by research in Hematology (11.3k citations), Genetics (5.3k citations), Public Health, Environmental and Occupational Health (7.3k citations), Pathology and Forensic Medicine (2.9k citations) and Oncology (4.0k citations). Michael J. Borowitz has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Daniel A. Arber, James W. Vardiman, Michelle M. Le Beau, Clara D. Bloomfield, Robert P. Hasserjian, Attilio Orazi, Mario Cazzola, Jürgen Thiele, Meenakshi Devidas and Stephen P. Hunger. Their work appears in journals such as Blood, Journal of Clinical Oncology, American Journal of Clinical Pathology, Leukemia and Biology of Blood and Marrow Transplantation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.